SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

SolarEdge appoints new CEO amid ongoing restructuring efforts

SentinelOne shares plummet as it faces competitive headwinds despite revenue growth

Tech boom sees six new Israelis join billionaires list

Interim Intel co-CEO: "We want to be the Western provider of leading-edge silicon"

Buzz

Most popular

Daily

Weekly

1

Tenable in talks to acquire cyber startup Vulcan for hundreds of millions

2

Israeli tech firm Silicom denies Iranian claims of Mossad and Unit 8200 links after cyber breach

3

Who will be Intel’s next CEO? Srouji, Murphy, and Tan lead the pack

4

Netflix faces $2.75 million class action lawsuit over Mike Tyson and Jake Paul fight glitches

5

Ex-Gett CEO Dave Waiser raises $46M for Accumulator to help founders navigate illiquid wealth

Biopharmaceuticals

3 stories about Biopharmaceuticals

Amotz Shemi Silenseed

Silenseed signs $7.8 million agreement with GIBF to create Chinese subsidiary

05.10.21|James Spiro

Proceeds from the investment are expected to provide Silenseed with liquidity to fund the company’s Phase III clinical trial

ירון פרג מנכל כאהר מדיקל

Cancer Treatment Company KAHR Medical Raises $18 Million

The company intends to use the funding to advance its immuno-oncology drug candidates, especially its lead product, DSP107, tested for the treatment of solid tumors

חדר מיון בית חולים שיבא תל השומר

InSight Biopharmaceuticals Buys Cancer Treatment Company CureTech

28.03.18|Lilach Baumer

As part of the deal, InSight commits to help develop CureTech’s lead product, which is currently in advanced clinical trials